Practical Use of RBX2660 for the Prevention of Recurrent Clostridioides difficile Infection-Reference-Cited by-同舟云学术

Practical Use of RBX2660 for the Prevention of Recurrent Clostridioides difficile Infection

Published:2023-01-25 Issue:8 Volume:118 Page:1303-1306
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterol

Author:

Feuerstadt Paul¹²,Allegretti Jessica R.³,Khanna Sahil⁴

Affiliation:

1. Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA;

2. PACT-Gastroenterology Center, Hamden, Connecticut, USA;

3. Division of Gastroenterology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA;

4. Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. Changes in prevalence of health care-associated infections in U.S. hospitals;Magill;N Engl J Med,2018

2. Trends in U.S. burden of Clostridioides difficile infection and outcomes;Guh;N Engl J Med,2020

3. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA);McDonald;Clin Infect Dis,2018

4. ACG clinical guidelines: Prevention, diagnosis, and treatment of Clostridioides difficile infections;Kelly;Am J Gastroenterol,2021

5. Burden of Clostridium difficile infection in the United States;Lessa;N Engl J Med,2015

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal Delivery of Probiotics: Materials, Strategies, and Applications;Advanced Materials;2024-06-04

2. Rise to the Challenge: Master the Management of Clostridioides difficile Infection;Mayo Clinic Proceedings;2024-06

3. Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection;Frontiers in Microbiomes;2024-05-16

4. The Progression of Microbiome Therapeutics for the Management of Gastrointestinal Diseases and Beyond;Gastroenterology;2024-05

5. Review article: The epidemiology and management of Clostridioides difficile infection—A clinical update;Alimentary Pharmacology & Therapeutics;2024-03-27